Memphis Bioworks™ Foundation Release: 10th Annual Memphis Musculoskeletal New Ventures Conference to be Held October 16-17
Published: Oct 03, 2012
The Musculoskeletal New Ventures Conference exposes venture capitalists (VCs) to new ideas, new companies and new opportunities. For 10 years, this conference has promoted dialog and built relationships between funding resources and entrepreneurs, while enabling emerging musculoskeletal companies to promote their ideas to business leaders worldwide. This year’s event is expected to be attended by dozens of VCs, representing millions of dollars in venture capital under management. They will hear from more than 20 diverse start-up companies that are developing new and emerging therapies for orthopedics and spine.
“Memphis is respected around the world as a leading community in the medical devices industry,” said Gary Stevenson, Managing Partner and co-founder, MB Venture Partners. “Successfully holding a conference of this magnitude for 10 consecutive years has not only showcased the research and intellectual property coming out of Memphis, it has demonstrated the city as a potential place to relocate or start a company. This conference provides a forum for exchanging ideas between surgeons, venture capitalists, industry leaders, researchers and entrepreneurs, which promotes industry growth to the benefit of everyone suffering from musculoskeletal conditions. We are proud to continue our productive working relationship with the Memphis Bioworks Foundation and all of our sponsors again this year.” The conference will be held at the FedEx Institute of Technology at the University of Memphis, October 16-17, 2012. Activities kick off with a Musculoskeletal Mixer at 7 p.m. on Monday, October 15 at the historic Peabody Hotel in downtown Memphis. The cost to attend the two-day conference as an academic/non-profit is $250. For a business attendee, the cost is $650.
The 10th Annual Musculoskeletal New Ventures Conference is hosted by MB Venture Partners and Memphis Bioworks Foundation. For more information on the conference or to register, visit www.mnvc.org.
About MB Venture Partners
MB Venture Partners is a Memphis-based venture capital firm that provides equity capital and strategic direction to life sciences start-ups. The Firm invests in medical device and biotechnology companies at various stages of development and has now funded 24 start-ups. The Firm is especially focused on product solutions for musculoskeletal conditions, where we have specific domain expertise and relationships to assist portfolio companies. For more information, visit www.mbventures.com.
About the Memphis Bioworks Foundation
The Memphis Bioworks Foundation, a not-for-profit organization, was formed to lead the collaboration among public, private, academic, and government entities to accelerate the growth of the bioscience industry in the region. Memphis Bioworks strives to leverage and expand the regional strengths in the biosciences through education, research, job training, and commercialization. Memphis Bioworks is leading the development of the UT-Baptist Research Park, which serves as the focal point of the city's biomedical economic development. For more information, visit www.memphisbioworks.org.